When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 14 Hits
  • Search Condition : Filter (MeSH = Neovascularization, Pathologic / drug therapy)
Species Resource
DNA material pCMX-N/RBP-J (R218H) (RDB03022) Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling.
Human and Animal Cells Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
Human and Animal Cells LLC(RCB0558) Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance.
Human and Animal Cells Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
Human and Animal Cells Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Human and Animal Cells A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Human and Animal Cells Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
Human and Animal Cells LM8 (RCB1450) Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma.
Human and Animal Cells Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.
Human and Animal Cells Acetylcholinesterase inhibitors attenuate angiogenesis.
Human and Animal Cells Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
Human and Animal Cells Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
Human and Animal Cells 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor.
Human and Animal Cells Saos-2 Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.